Molecule intelOpportunity: StrongEssential

Estradiol

26 brands · 17 companies · product forms

ATC: G03CA03 2 DRAP alerts

Opportunity snapshot

Launch attractiveness
63
Market saturation
45
Price room
100
Regulatory risk
60
26
brands
17
companies
Rs 843.15
median price
10
price points
8.19x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 19%

Price room

Across observed sources and strengths
CheapestRs 134.79
MedianRs 843.15
Most expensiveRs 1,104.41
Spread8.19×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 8.19x across 10 trusted points (Rs 134.79-1104.41). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 11 live products for Estradiol — each links to its own medicine page.

Regulatory alerts

Shortage exposurelatest 2026-05-06
Risk Communication and Awareness Plan of Pharmacovigilance Activities (Edition 01)
Strategic Plan 2026-2030

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(55) + 15% supply-disruption(60), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

17 canonical companies and 26 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 8.19x across 10 trusted points (Rs 134.79-1104.41). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

2 DRAP alert(s), latest 2026-05-06.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.